


Healthcare Industry NewsFeed
HSMN NewsFeed - 24 May 2013
PBAC Approves XIFAXAN(R) (Rifaxamin α) 550 mg Cost Effectiveness in Australia
PBAC Approves XIFAXAN(R) (Rifaxamin α) 550 mg Cost Effectiveness in Australia
HSMN NewsFeed - 23 May 2013
Study Finds 35 to 42 Percent Daily Cost Savings for Hospitals Using Flexi-Seal(R) Fecal Management System
Study Finds 35 to 42 Percent Daily Cost Savings for Hospitals Using Flexi-Seal(R) Fecal Management System
HSMN NewsFeed - 23 May 2013
Astellas Receives Marketing Authorization for VESOMNI(TM) from the Netherlands Medicines Evaluation Board
Astellas Receives Marketing Authorization for VESOMNI(TM) from the Netherlands Medicines Evaluation Board
HSMN NewsFeed - 22 May 2013
KCI Launches Prevena(TM) Peel & Place(TM) Dressing with V.A.C.(R) Therapy Connector
KCI Launches Prevena(TM) Peel & Place(TM) Dressing with V.A.C.(R) Therapy Connector
HSMN NewsFeed - 22 May 2013
Syros Pharmaceuticals Appoints Eric R. Olson, Ph.D. as Chief Scientific Officer
Syros Pharmaceuticals Appoints Eric R. Olson, Ph.D. as Chief Scientific Officer
HSMN NewsFeed - 22 May 2013
Industry Leader John Reynders Joins Moderna Therapeutics as Chief Information Officer
Industry Leader John Reynders Joins Moderna Therapeutics as Chief Information Officer
HSMN NewsFeed - 21 May 2013
Accumed Radial Systems, LLC Names Michael Pisano, PhD, as President and Chief Executive Officer
Accumed Radial Systems, LLC Names Michael Pisano, PhD, as President and Chief Executive Officer
HSMN NewsFeed - 21 May 2013
OrbusNeich seizes Boston Scientific stents in Germany as part of patent infringement proceedings
OrbusNeich seizes Boston Scientific stents in Germany as part of patent infringement proceedings
HSMN NewsFeed - 21 May 2013
Philips CX50 xMATRIX now offers world-class interventional and diagnostic features on single portable system
Philips CX50 xMATRIX now offers world-class interventional and diagnostic features on single portable system
HSMN NewsFeed - 21 May 2013
West Virginia University Hospitals Images Patients with Toshiba’s Most Advanced CT Technology
West Virginia University Hospitals Images Patients with Toshiba’s Most Advanced CT Technology
HSMN NewsFeed - 20 May 2013
Sequent Medical, Inc. Launches New SL Family of WEB Aneurysm Embolization Devices
Sequent Medical, Inc. Launches New SL Family of WEB Aneurysm Embolization Devices
HSMN NewsFeed - 20 May 2013
Covidien Receives FDA 510(k) Clearance for Nellcor(TM) Pulse Oximetry Motion Claims
Covidien Receives FDA 510(k) Clearance for Nellcor(TM) Pulse Oximetry Motion Claims
HSMN NewsFeed - 17 May 2013
Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013
Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013
HSMN NewsFeed - 16 May 2013
InspireMD Announces Reimbursement Coverage for MGuard(TM) Coronary Embolic Protection Stent
InspireMD Announces Reimbursement Coverage for MGuard(TM) Coronary Embolic Protection Stent
HSMN NewsFeed - 15 May 2013
Achillion Appoints Dr. David Apelian as Chief Medical Officer and Expands Clinical Operations Team
Achillion Appoints Dr. David Apelian as Chief Medical Officer and Expands Clinical Operations Team
HSMN NewsFeed - 15 May 2013
RaySearch Laboratories: RaySearch receives 510(k) clearance for RayStation(R) 3.5
RaySearch Laboratories: RaySearch receives 510(k) clearance for RayStation(R) 3.5
HSMN NewsFeed - 15 May 2013
Bayer Initiates Phase III Trial of Stivarga(R) (regorafenib) Tablets in Patients with Advanced Liver Cancer
Bayer Initiates Phase III Trial of Stivarga(R) (regorafenib) Tablets in Patients with Advanced Liver Cancer
HSMN NewsFeed - 14 May 2013
Suneva Medical Announces Results of Its Pivotal ArteFill(R) Acne Scar Study
Suneva Medical Announces Results of Its Pivotal ArteFill(R) Acne Scar Study
HSMN NewsFeed - 13 May 2013
Vision-Sciences Appoints Howard Zauberman as Interim Chief Executive Officer
Vision-Sciences Appoints Howard Zauberman as Interim Chief Executive Officer
HSMN NewsFeed - 13 May 2013
Use of TYRX Antibacterial Envelope Associated with Extremely Low 90-Day Cardiac Device Infection Rates
Use of TYRX Antibacterial Envelope Associated with Extremely Low 90-Day Cardiac Device Infection Rates
